What are CVS Health's primary business segments and what did they contribute in 2016?

CVS Health operates through three main segments: Pharmacy Services, Retail/LTC, and Corporate. The Pharmacy Services segment manages pharmacy benefit solutions, while the Retail/LTC segment encompasses retail pharmacies, long-term care pharmacies, and MinuteClinics. The provided filing details the scale of operations for these segments in 2016, with Prescription Drugs being the largest revenue contributor within the Retail/LTC segment at 75%.

What is the company's strategy for growth and competitive advantage?

CVS Health's strategy centers on being a pharmacy innovation company that helps people achieve better health through an integrated model. Key strategies include driving innovation, increasing access to quality care, delivering better health outcomes, and lowering overall healthcare costs. They leverage their extensive retail footprint, PBM capabilities, and digital initiatives to achieve these goals and differentiate themselves in the competitive healthcare landscape.

What are the key risks facing CVS Health as outlined in the 10-K?

The company identifies several key risks, including declining gross margins in PBM and pharmacy industries due to competitive pressures and reimbursement rate changes, potential impacts from changes in U.S. health policy and regulation (including the Affordable Care Act), a highly competitive business environment, and risks associated with the failure or disruption of its IT systems and information security. Regulatory compliance across its broad operations is also a significant concern.

How does CVS Health manage its capital and return value to shareholders?

The company actively manages its capital through cash flow from operations, borrowings, and sale-leaseback transactions. For shareholder returns, CVS Health has historically paid consistent quarterly cash dividends and has substantial authorized share repurchase programs in place. The filing details significant amounts available for future repurchases as of December 31, 2016.

CVS 10-K FY2016 Annual Report — Revenue, Net Income, EPS

Summary

CVS Health Corporation, in its 2016 10-K filing, presented a robust business model centered on pharmacy innovation and integrated healthcare solutions. The company operates across three distinct segments: Pharmacy Services, Retail/LTC, and Corporate. The Pharmacy Services segment, driven by its Pharmacy Benefit Manager (PBM) operations under CVS Caremark, processed approximately 1.2 billion prescriptions in 2016, offering a comprehensive suite of services including formulary management, specialty pharmacy, and Medicare Part D benefits through SilverScript. The Retail/LTC segment encompasses over 9,700 retail pharmacy locations, including those within Target stores, alongside its Long-Term Care (LTC) pharmacy operations through Omnicare, and the growing MinuteClinic health clinics. Prescription drugs remained the dominant revenue driver in this segment, accounting for 75% of net revenues in 2016. The company continued its strategic focus on enhancing customer access, improving health outcomes, and managing costs through innovative programs and digital integration.

Financial Highlights

59 data points

Beta

Revenue

$177.55B

0.2% Gross Margin

Net Income

$5.32B

0.0% Net Margin

EPS (Diluted)

$4.90

Total Assets

$94.46B

Cash & Equivalents

$3.37B

Free Cash Flow

$7.92B

Financial Statements

Beta

Revenue	$177.55B
Cost of Revenue	$148.67B
Gross Profit	$28.86B
Operating Expenses	$18.45B
Operating Income	$10.39B
Interest Expense	$1.08B
Net Income	$5.32B
EPS (Basic)	$4.93
EPS (Diluted)	$4.90
Shares Outstanding (Basic)	1.07B
Shares Outstanding (Diluted)	1.08B

Key Highlights

1CVS Health operates a diversified business model with three reportable segments: Pharmacy Services, Retail/LTC, and Corporate.
2The Pharmacy Services segment, led by CVS Caremark, processed approximately 1.2 billion prescriptions in 2016, highlighting its significant role in pharmacy benefit management.
3The Retail/LTC segment features a vast network of over 9,700 retail locations, including pharmacies within Target stores, complemented by Long-Term Care (LTC) operations and 1,100+ MinuteClinic locations.
4Prescription drugs constituted 75% of net revenues for the Retail/LTC segment in 2016, underscoring the centrality of pharmaceutical sales to the company's retail operations.
5CVS Health is actively investing in digital tools and innovation, such as CVS PayTM, to enhance customer engagement and convenience across its services.
6The company demonstrated a strong commitment to returning capital to shareholders through substantial share repurchase programs and consistent dividend payments.
7The acquisition of Omnicare broadened CVS Health's reach into long-term care pharmacy services, further integrating its healthcare offerings.

CVS HEALTH Corp Annual Report, Year Ended Dec 31, 2016

Summary

Financial Highlights

Key Highlights

Frequently Asked Questions